Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Recerca en genètica de malalties neurològiques

IP: Antonio Luis Andreu Périz
Collaborators: Elena García Arumí, Mercè Boada Rovira, Esteve Ribera Pascuet, Rafael Simó Canonge, Josep Gamez Carbonell, Maria Mar Hernandez Guillamon, Ramon Martí Seves
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 36600
Reference: 2005SGR 00971
Duration: 01/01/2006 - 30/05/2010

Disfunción endometrial en la diabetes del anciano: influencia de los factores angiogénicos y antiangiogénicos

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual
Funding agency: Instituto de Salud Carlos III
Funding: 66700
Reference: PI040680
Duration: 01/01/2005 - 28/11/2007

Factores angiogénicos y antiangiogénicos en la retinopatía diabética: cuantificación proteica en humos vítreo y estudio de expresión génica en retina.

IP: Rafael Simó Canonge
Collaborators: José García Arumí, Inés de Torres Ramirez, Cristina Hernández Pascual
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 119000
Reference: SAF2003-00550
Duration: 15/12/2003 - 14/12/2006

Ministerio de Ciencia

Factores angiogénicos, antiangiogénicos y actividad inmunológica en el humor vítreo de los pacientes con retinopatía diabética

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Fundació Institut de Recerca HUVH
Funding: 13000
Reference: PRED/IR-HUVH/07/2002
Duration: 01/01/2003 - 31/12/2006

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Pedro Serrano Pérez

Pedro Serrano Pérez

Research technician
Psychiatry, Mental Health and Addictions
Read more
Sergio Lopez Fernandez

Sergio Lopez Fernandez

Predoctoral researcher
Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Paula Fernández Álvarez

Paula Fernández Álvarez

Research technician
Genetics Medicine
Read more
Coro Bescós Atin

Coro Bescós Atin

Head of group
New Technologies and Craniofacial Microsurgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.